L&C BIO Co.,LTD (KOSDAQ:290650)
75,700
+300 (0.40%)
Mar 20, 2026, 3:30 PM KST
253.74% (1Y)
| Market Cap | 1.88T +288.4% |
| Revenue (ttm) | 79.99B +19.4% |
| Net Income | 78.00B |
| EPS | 3,050.54 |
| Shares Out | 24.85M |
| PE Ratio | 24.60 |
| Forward PE | 132.57 |
| Dividend | 50.00 (0.07%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 170,859 |
| Average Volume | 379,609 |
| Open | 76,200 |
| Previous Close | 75,400 |
| Day's Range | 74,900 - 77,400 |
| 52-Week Range | 18,490 - 125,000 |
| Beta | 1.47 |
| RSI | 42.38 |
| Earnings Date | Mar 24, 2026 |